Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis

被引:8
|
作者
Christopeit, M. [1 ]
Badbaran, A. [1 ]
Zabelina, T. [1 ]
Zeck, G. [1 ]
Fehse, B. [1 ]
Ayuk, F. [1 ]
Wolschke, C. [1 ]
Kroeger, N. [1 ]
机构
[1] Univ Med Ctr Hamburg, Dept Stem Cell Transplantat, Hamburg, Germany
关键词
MYELOPROLIFERATIVE NEOPLASMS; COMPETING RISK; PROGNOSTIC IMPACT; CALR MUTATIONS; JAK2; CLINICIAN; 1-LIKE; GUIDE; MPL;
D O I
10.1038/bmt.2016.128
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:1391 / 1393
页数:3
相关论文
共 50 条
  • [11] Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact
    A Tefferi
    T L Lasho
    C Finke
    A A Belachew
    E A Wassie
    R P Ketterling
    C A Hanson
    A Pardanani
    Leukemia, 2014, 28 : 1568 - 1570
  • [12] Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact
    Tefferi, A.
    Lasho, T. L.
    Finke, C.
    Belachew, A. A.
    Wassie, E. A.
    Ketterling, R. P.
    Hanson, C. A.
    Pardanani, A.
    LEUKEMIA, 2014, 28 (07) : 1568 - 1570
  • [13] Determinants of long-term outcome in type 1 calreticulin-mutated myelofibrosis
    Natasha Szuber
    Terra L. Lasho
    Christy Finke
    Curtis A. Hanson
    Rhett P. Ketterling
    Animesh Pardanani
    Naseema Gangat
    Ayalew Tefferi
    Leukemia, 2019, 33 : 780 - 785
  • [14] Determinants of long-term outcome in type 1 calreticulin-mutated myelofibrosis
    Szuber, Natasha
    Lasho, Terra L.
    Finke, Christy
    Hanson, Curtis A.
    Ketterling, Rhett P.
    Pardanani, Animesh
    Gangat, Naseema
    Tefferi, Ayalew
    LEUKEMIA, 2019, 33 (03) : 780 - 785
  • [15] Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution
    Cabagnols, X.
    Defour, J. P.
    Ugo, V.
    Ianotto, J. C.
    Mossuz, P.
    Mondet, J.
    Girodon, F.
    Alexandre, J. H.
    Mansier, O.
    Viallard, J. F.
    Lippert, E.
    Murati, A.
    Mozziconacci, M. J.
    Saussoy, P.
    Vekemans, M. C.
    Knoops, L.
    Pasquier, F.
    Ribrag, V.
    Solary, E.
    Plo, I.
    Constantinescu, S. N.
    Casadevall, N.
    Vainchenker, W.
    Marzac, C.
    Bluteau, O.
    LEUKEMIA, 2015, 29 (01) : 249 - 252
  • [16] Outcome of allogeneic stem cell transplantation in patients with myelofibrosis
    M Ditschkowski
    D W Beelen
    R Trenschel
    M Koldehoff
    A H Elmaagacli
    Bone Marrow Transplantation, 2004, 34 : 807 - 813
  • [17] Outcome of allogeneic stem cell transplantation in patients with myelofibrosis
    Ditschkowski, M
    Beelen, DW
    Trenschel, R
    Koldehoff, M
    Elmaagacli, AH
    BONE MARROW TRANSPLANTATION, 2004, 34 (09) : 807 - 813
  • [18] Safety and outcome of allogeneic stem cell transplantation in myelofibrosis
    Markiewicz, Miroslaw
    Mietla, Monika Dzierzak
    Wieczorkiewicz, Agata
    Mizia, Sylwia
    Helbig, Grzegorz
    Kopera, Malgorzata
    Bialas, Krzysztof
    Rybicka, Malwina
    Matyja, Mariusz
    Koclega, Anna
    Sedlak, Lech
    Oleksy, Tomasz
    Raman, Sundar
    Kyrcz-Krzemien, Slawomira
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (03) : 222 - 228
  • [19] Differential Association of Calreticulin Type 1 and Type 2 Mutations with Myelofibrosis and Essential Thrombocytemia: Relevance for Disease Evolution
    Cabagnols, Xenia
    Defour, Jean-Philippe
    Ugo, Valerie
    Ianotto, Jean Christophe
    Mossuz, Pascal
    Mondet, Julie
    Girodon, Francois
    Ji-Hye, Alexandre
    Mansier, Olivier
    Viallard, Jean Francois
    Lippert, Eric
    Murati, Anne
    Mozziconacci, M. J.
    Legrand, Ollivier
    Saussoy, Pascale
    Vekemans, Marie-Christianne
    Knoops, Laurent
    Pasquier, Florence
    Ribrag, Vincent
    Solary, Eric
    Plo, Isabelle
    Constantinescu, Stefan N.
    Casadevall, Nicole
    Vainchenker, William
    Marzac, Christophe
    Bluteau, Olivier
    BLOOD, 2014, 124 (21)
  • [20] Myeloablative allogeneic haematopoietic stem cell transplantation for myelofibrosis with myeloid metaplasia
    Ditschkowski, M.
    Keller, M. T.
    Elmaagacli, A. H.
    Trenschel, R.
    Steckel, N. K.
    Koldehoff, M.
    Schulte, C.
    Beelen, D.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S9 - S10